Dallas, TX, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the fourth quarter and ...
Strong start to the year with sales growth of 27% on a reported basis and strong adjusted margin expansion Reported first-quarter net loss from continuing operations of $1.32 per share with adjusted ...
Enovis Corporation’s ENOV fourth-quarter net sales reached $455 million, up 11% Y/Y, including 8% organic growth, beating the consensus of $445.36 million. Fourth quarter results reflect continued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results